Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 42 | $10,085,425 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 14 Feb 2024 18:43 | CBAY | CymaBay Therapeutics Inc | DORLING JANET | Director | 12 Feb 2024 | Sale | 6,000 | 31.9748 | 191,849 | D |
| 22 Jan 2024 18:59 | CBAY | CymaBay Therapeutics Inc | MCWHERTER CHARLES | President of R&D | 19 Jan 2024 | Sale | 3,125 | 23.676 | 73,988 | D |
| 22 Jan 2024 18:59 | CBAY | CymaBay Therapeutics Inc | MCWHERTER CHARLES | President of R&D | 19 Jan 2024 | Sale | 8,334 | 23.676 | 197,316 | D |
| 22 Jan 2024 18:59 | CBAY | CymaBay Therapeutics Inc | MCWHERTER CHARLES | President of R&D | 19 Jan 2024 | Sale | 2,778 | 23.6641 | 65,739 | D |
| 22 Jan 2024 18:59 | CBAY | CymaBay Therapeutics Inc | MCWHERTER CHARLES | President of R&D | 19 Jan 2024 | Sale | 1,916 | 23.6641 | 45,340 | D |
| 22 Jan 2024 18:59 | CBAY | CymaBay Therapeutics Inc | MCWHERTER CHARLES | President of R&D | 19 Jan 2024 | Sale | 2,250 | 23.6721 | 53,262 | D |
| 16 Jan 2024 19:07 | CBAY | CymaBay Therapeutics Inc | MENOLD DANIEL | Vice President, Finance | 16 Jan 2024 | Sale | 10,000 | 23.5806 | 235,806 | D |
| 16 Jan 2024 19:07 | CBAY | CymaBay Therapeutics Inc | QUINLAN PAUL T | General Counsel | 16 Jan 2024 | Sale | 5,000 | 23.5796 | 117,898 | D |
| 10 Jan 2024 20:35 | CBAY | CymaBay Therapeutics Inc | DORLING JANET | Director | 10 Jan 2024 | Sale | 6,000 | 23.8574 | 143,144 | D |
| 18 Dec 2023 20:04 | CBAY | CymaBay Therapeutics Inc | MCWHERTER CHARLES | President of R&D | 18 Dec 2023 | Sale | 6,504 | 21.4796 | 139,703 | D |
| 18 Dec 2023 20:04 | CBAY | CymaBay Therapeutics Inc | MCWHERTER CHARLES | President of R&D | 18 Dec 2023 | Sale | 4,828 | 21.4867 | 103,738 | D |
| 15 Dec 2023 16:38 | CBAY | CymaBay Therapeutics Inc | MENOLD DANIEL | Vice President, Finance | 15 Dec 2023 | Sale | 11,497 | 21.9883 | 252,799 | D |
| 15 Dec 2023 16:38 | CBAY | CymaBay Therapeutics Inc | MENOLD DANIEL | Vice President, Finance | 15 Dec 2023 | Sale | 10,000 | 21.9847 | 219,847 | D |
| 15 Dec 2023 16:35 | CBAY | CymaBay Therapeutics Inc | QUINLAN PAUL T | General Counsel | 15 Dec 2023 | Sale | 5,000 | 21.9805 | 109,902 | D |
| 11 Dec 2023 19:03 | CBAY | CymaBay Therapeutics Inc | SHAH SUJAL | Chief Executive Officer | 11 Dec 2023 | Sale | 890 | 20.81 | 18,521 | D |
| 11 Dec 2023 19:03 | CBAY | CymaBay Therapeutics Inc | SHAH SUJAL | Chief Executive Officer | 11 Dec 2023 | Sale | 63,975 | 19.9867 | 1,278,649 | D |
| 11 Dec 2023 19:01 | CBAY | CymaBay Therapeutics Inc | DORLING JANET | Director | 11 Dec 2023 | Sale | 6,000 | 20.0703 | 120,422 | D |
| 17 Nov 2023 17:58 | CBAY | CymaBay Therapeutics Inc | MCWHERTER CHARLES | President of R&D | 17 Nov 2023 | Sale | 11,342 | 18.2766 | 207,293 | D |
| 17 Nov 2023 17:57 | CBAY | CymaBay Therapeutics Inc | QUINLAN PAUL T | General Counsel | 15 Nov 2023 | Sale | 5,000 | 17.3778 | 86,889 | D |
| 14 Nov 2023 18:00 | CBAY | CymaBay Therapeutics Inc | SHAH SUJAL | Chief Executive Officer | 13 Nov 2023 | Sale | 20,855 | 15.8883 | 331,350 | D |
| 14 Nov 2023 18:00 | CBAY | CymaBay Therapeutics Inc | SHAH SUJAL | Chief Executive Officer | 13 Nov 2023 | Sale | 44,008 | 15.8905 | 699,309 | D |
| 14 Nov 2023 17:56 | CBAY | CymaBay Therapeutics Inc | DORLING JANET | Director | 10 Nov 2023 | Sale | 7,000 | 15.2428 | 106,700 | D |
| 18 Oct 2023 18:22 | CBAY | CymaBay Therapeutics Inc | MCWHERTER CHARLES | President of R&D | 18 Oct 2023 | Sale | 21,743 | 14.0708 | 305,941 | D |
| 18 Oct 2023 18:21 | CBAY | CymaBay Therapeutics Inc | QUINLAN PAUL T | General Counsel | 16 Oct 2023 | Sale | 5,000 | 13.7596 | 68,798 | D |
| 10 Oct 2023 17:04 | CBAY | CymaBay Therapeutics Inc | SHAH SUJAL | Chief Executive Officer | 09 Oct 2023 | Sale | 64,861 | 14.204 | 921,286 | D |
| 29 Sep 2023 17:54 | CBAY | CymaBay Therapeutics Inc | EMSTER KURT VON | Director | 29 Sep 2023 | Sale | 15,921 | 15.6821 | 249,675 | D |
| 19 Sep 2023 17:27 | CBAY | CymaBay Therapeutics Inc | MCWHERTER CHARLES | President of R&D | 18 Sep 2023 | Sale | 21,746 | 16.2206 | 352,733 | D |
| 19 Sep 2023 17:23 | CBAY | CymaBay Therapeutics Inc | QUINLAN PAUL T | General Counsel | 15 Sep 2023 | Sale | 24,000 | 16.8715 | 404,916 | D |
| 19 Sep 2023 17:23 | CBAY | CymaBay Therapeutics Inc | QUINLAN PAUL T | General Counsel | 15 Sep 2023 | Sale | 24,000 | 16.8707 | 404,897 | D |
| 19 Sep 2023 17:23 | CBAY | CymaBay Therapeutics Inc | QUINLAN PAUL T | General Counsel | 15 Sep 2023 | Sale | 5,000 | 16.8656 | 84,328 | D |
| 18 Aug 2023 19:03 | CBAY | CymaBay Therapeutics Inc | MCWHERTER CHARLES | President of R&D | 18 Aug 2023 | Sale | 21,746 | 11.4669 | 249,359 | D |
| 16 Aug 2023 16:57 | CBAY | CymaBay Therapeutics Inc | QUINLAN PAUL T | General Counsel | 15 Aug 2023 | Sale | 5,000 | 11.9101 | 59,550 | D |
| 11 Aug 2023 18:26 | CBAY | CymaBay Therapeutics Inc | MENOLD DANIEL | Vice President, Finance | 09 Aug 2023 | Sale | 20,945 | 12.3535 | 258,744 | D |
| 19 Jul 2023 18:05 | CBAY | CymaBay Therapeutics Inc | MCWHERTER CHARLES | President of R&D | 18 Jul 2023 | Sale | 21,749 | 11.4267 | 248,519 | D |
| 14 Jul 2023 18:52 | CBAY | CymaBay Therapeutics Inc | QUINLAN PAUL T | General Counsel | 14 Jul 2023 | Sale | 5,000 | 11.81 | 59,050 | D |
| 30 Jun 2023 16:51 | CBAY | CymaBay Therapeutics Inc | QUINLAN PAUL T | General Counsel | 30 Jun 2023 | Sale | 5,000 | 10.05 | 50,250 | D |
| 21 Jun 2023 18:46 | CBAY | CymaBay Therapeutics Inc | MCWHERTER CHARLES | President of R&D | 20 Jun 2023 | Sale | 21,749 | 8.1559 | 177,383 | D |
| 19 May 2023 18:00 | CBAY | CymaBay Therapeutics Inc | MCWHERTER CHARLES | President of R&D | 18 May 2023 | Sale | 21,749 | 9.0757 | 197,387 | D |
| 17 May 2023 19:11 | CBAY | CymaBay Therapeutics Inc | QUINLAN PAUL T | General Counsel | 15 May 2023 | Sale | 5,000 | 10.3662 | 51,831 | D |
| 17 Apr 2023 19:24 | CBAY | CymaBay Therapeutics Inc | KIM DENNIS D | Chief Medical Officer | 17 Apr 2023 | Sale | 112,219 | 9.5397 | 1,070,536 | D |
| 17 Apr 2023 19:24 | CBAY | CymaBay Therapeutics Inc | KIM DENNIS D | Chief Medical Officer | 13 Apr 2023 | Sale | 7,781 | 8.9809 | 69,880 | D |
| 30 Mar 2023 17:39 | CBAY | CymaBay Therapeutics Inc | KIM DENNIS D | Chief Medical Officer | 28 Mar 2023 | Sale | 100 | 8.985 | 898 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)